Enzo Bonora

1983–2024 年に発表

140
論文数
32,097
被引用数
90
h 指数
139
i10 指数

被引用数

Enzo Bonora の年別被引用数1964 年: 被引用 1 件1972 年: 被引用 1 件1986 年: 被引用 2 件1987 年: 被引用 5 件1988 年: 被引用 5 件1989 年: 被引用 9 件1990 年: 被引用 19 件1991 年: 被引用 29 件1992 年: 被引用 28 件1993 年: 被引用 18 件1994 年: 被引用 23 件1995 年: 被引用 32 件1996 年: 被引用 37 件1997 年: 被引用 40 件1998 年: 被引用 42 件1999 年: 被引用 48 件2000 年: 被引用 91 件2001 年: 被引用 94 件2002 年: 被引用 163 件2003 年: 被引用 234 件2004 年: 被引用 293 件2005 年: 被引用 261 件2006 年: 被引用 253 件2007 年: 被引用 211 件2008 年: 被引用 225 件2009 年: 被引用 196 件2010 年: 被引用 221 件2011 年: 被引用 259 件2012 年: 被引用 249 件2013 年: 被引用 337 件2014 年: 被引用 364 件2015 年: 被引用 347 件2016 年: 被引用 341 件2017 年: 被引用 300 件2018 年: 被引用 259 件2019 年: 被引用 904 件2020 年: 被引用 979 件2021 年: 被引用 863 件2022 年: 被引用 700 件2023 年: 被引用 486 件2024 年: 被引用 705 件2025 年: 被引用 332 件2026 年: 被引用 9 件1965〜1971 年は被引用が無いため表示していません1973〜1985 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,895 件、この内訳の 20.5%中国: 引用元論文 1,243 件、この内訳の 8.8%イタリア: 引用元論文 1,237 件、この内訳の 8.8%イギリス: 引用元論文 1,077 件、この内訳の 7.6%ドイツ: 引用元論文 580 件、この内訳の 4.1%オーストラリア: 引用元論文 447 件、この内訳の 3.2%スペイン: 引用元論文 414 件、この内訳の 2.9%スウェーデン: 引用元論文 367 件、この内訳の 2.6%カナダ: 引用元論文 363 件、この内訳の 2.6%フランス: 引用元論文 359 件、この内訳の 2.6%オランダ: 引用元論文 358 件、この内訳の 2.5%日本: 引用元論文 346 件、この内訳の 2.5%
0%20.5%その他 31.3%

分野

  • Medicine75.4%
  • Biochemistry, Genetics and Molecular Biology15.6%
  • Immunology and Microbiology2.7%
  • Nursing1.4%
  • Neuroscience1.4%
  • Health Professions0.7%
  • その他2.8%

トピック

  • Liver Disease Diagnosis and Treatment7.3%
  • Diabetes, Cardiovascular Risks, and Lipoproteins7%
  • Diabetes Treatment and Management3.3%
  • Diet, Metabolism, and Disease2.9%
  • Adipokines, Inflammation, and Metabolic Diseases2.7%
  • Metabolism, Diabetes, and Cancer2.6%
  • その他74.2%

共著者

全論文

検索で開く
  1. Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

    著者: , , - New England Journal of Medicine 2010 被引用: 1,904

  2. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

    著者: , , , , , , , - Diabetes Care 2000 被引用: 2,468

  3. Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis

    著者: , , , - Diabetes Care 2018 被引用: 626

  4. Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study

    著者: , , , , , , , , , , , , - BMC Medicine 2021 被引用: 164

  5. Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes

    著者: , , , , , , , , , , , , - Circulation Research 2010 被引用: 1,458

  6. Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)

    著者: , , , , , , , , - Diabetes Care 2021 被引用: 190

  7. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , A. Dudina, Alec Vahanian, A. John Camm, R. De Caterina, V. Dean, Kenneth Dickstein, Christian Funck‐Brentano, G. Filippatos, Irene Hellemans, S. D. Kristensen, Keith McGregor, U Sechtem, Sigmund Silber, Michał Tendera, P. Widimsky, José Luis Zamorano, Document reviewers:, Irene Hellemans, Attila Altiner, Enzo Bonora, Paul N. Durrington, R. Fagard, Simona Giampaoli, Harry Hemingway, Jan Håkansson, Sverre E. Kjeldsen, M. Lytken Larsen, G. Mancia, Athanasios Manolis, Kristina Orth‐Gomér, Terje Pedersen, Mike Rayner, L Rydén, Mario R. Sammut, Neil Schneiderman, Anton F. H. Stalenhoef, Lâle Tokgözoğlu, Olov Wiklund, Antonis Zampelas - European Heart Journal 2007 被引用: 3,758

  8. HOMA-Estimated Insulin Resistance Is an Independent Predictor of Cardiovascular Disease in Type 2 Diabetic Subjects

    著者: , , , , , , , , , , , , , , - Diabetes Care 2002 被引用: 610

  9. Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2013 被引用: 256

  10. Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 randomized trial)

    著者: , , , , , , , , , - Hepatology 2013 被引用: 349

  11. Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes

    著者: , , - Human Reproduction 2017 被引用: 153

  12. Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

    著者: , , , , , , - Thyroid 2018 被引用: 152

  13. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis

    著者: , , , , , , - Metabolism 2017 被引用: 358

  14. Divergences in Insulin Resistance Between the Different Phenotypes of the Polycystic Ovary Syndrome

    著者: , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2013 被引用: 250

  15. Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes

    著者: , , , , , , , , , , , , , , , , , , - Diabetes 2016 被引用: 256

  16. Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes Mellitus

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jiemin Pan, Juan Pedro‐Botet, Željko Reiner, Carlo Maria Rotella, Rafael Simó, Masami Tanaka, Eugenia Tedeschi-Reiner, David Twum-Barima, Giacomo Zoppini, Vincent J. Carey - Circulation 2013 被引用: 258

  17. Loss of ZnT8 function protects against diabetes by enhanced insulin secretion

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jason Flannick, Maddalena Trombetta, Enzo Bonora, Claes B. Wolheim, Leena Sarelin, Riccardo C. Bonadonna, Patrik Rorsman, Benjamin Davies, Julia Brosnan, Mark I. McCarthy, Timo Otonkoski, Jens O. Lagerstedt, Guy A. Rutter, Jesper Gromada, Anna L. Gloyn, Tiinamaija Tuomi, Leif Groop - Nature Genetics 2019 被引用: 149

  18. Predictors of Estimated GFR Decline in Patients with Type 2 Diabetes and Preserved Kidney Function

    著者: , , , , , , - Clinical Journal of the American Society of Nephrology 2012 被引用: 232

  19. Insulin Resistance as Estimated by Homeostasis Model Assessment Predicts Incident Symptomatic Cardiovascular Disease in Caucasian Subjects From the General Population

    著者: , , , , , , , - Diabetes Care 2007 被引用: 352

  20. Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ciro Iovine, Davide Lauro, Sergio Leotta, Elisabetta Dall’Aglio, Emanuela Cannarsa, Laura Tonutti, Giuseppe Pugliese, Antonio Bossi, Roberto Anichini, Francesco Dotta, A. Di Benedetto, Giuseppe Citro, D. Antenucci, Lucia Ricci, Francesco Giorgino, Costanza Santini, Agostino Gnasso, Salvatore De Cosmo, D. Zavaroni, Monica Vedovato, Agostino Consoli, Maria Calabrese, Paolo di Bartolo, Paolo Fornengo, Gabriele Riccardi, Olga Vaccaro, Maria Masulli, Antonio Nicolucci, Aldo P. Maggioni, Giorgio Sesti, Paolo Mocarelli, Giuseppe Lucisano, Michele Sacco, Stefano Signorini, Fabrizio Cappellini, Gabriele Riccardi, Massimo Boemi, Federica D’Angelo, R. Giansanti, Laura Tanase, Luigi Lanari, I Testa, Lucia Ricci, Francesca Pancani, A. Ranchelli, Paolo Vagheggi, Alessia Scatona, Lucia Fontana, Francesco Giorgino, Luigi Laviola, Lucia Tarantino, Claudia Ippolito, Vittoria Gigantelli, Mariangela Manicone, Eleonora Conte, Roberto Trevisan, Cristiana Scaranna, Rossella Rota, A. Corsi, Alessandro Roberto Dodesini, Giulio Marchesini Reggiani, Luca Montesi, Natalia Mazzella, Gabriele Forlani, Chiara Caselli, Raffaella Di Luzio, Arianna Mazzotti, Antimo Aiello, Angelina Barrea, Antonio Musto ほか 339 名 - The Lancet Diabetes & Endocrinology 2017 被引用: 290

  21. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.

    著者: , , , , , , , , - Diabetes 1998 被引用: 844

  22. Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9

    著者: , , , , , , , , , , , , , , , , , - BMJ Open Diabetes Research & Care 2020 被引用: 88

  23. The Pros and Cons of Diagnosing Diabetes With A1C

    著者: , - Diabetes Care 2011 被引用: 375

  24. Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis

    著者: , , , , , , - Metabolism 2018 被引用: 111